Histological evaluation of paraffin-embedded tumors demonstrated decreased tumor content following IT CXCL9/10-DC as monotherapy, or in combination with anti-PD-1, as determined by the ratio of PanC/K+ (tumor) areas to total tissue area (Figures S6B and S6C). The gene discussed is CXCL9; the disease is neoplasm.